Clinical Trials Logo

Filter by:
NCT ID: NCT02607371 Completed - Atrial Fibrillation Clinical Trials

Anticoagulation Preference by AF Patients Study

PRiSMA-AF
Start date: August 27, 2015
Phase: N/A
Study type: Observational

The main research question of this patient survey is to assess AF (Atrial Fibrillation) patients' preferences associated with different attributes which describe the different available anticoagulation treatment options (Vitamin K Antagonists [VKA] or New Oral Anticoagulants [NOACs] and, in case of NOACs, Apixaban, Dabigatran, Edoxaban or Rivaroxaban). VKAs (Marcoumar®, Sintrom ®) will be grouped together and compared to Rivaroxaban.

NCT ID: NCT02605447 Completed - Clinical trials for Coronary Artery Disease

EVOLVE Short DAPT Study

Start date: February 16, 2016
Phase: Phase 4
Study type: Interventional

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with a SYNERGY Stent System.

NCT ID: NCT02605330 Completed - Clinical trials for Fibrinogens, Abnormal

Kinetics of Plasma Fibrinogen in Cardiac Surgery

Start date: November 2015
Phase: N/A
Study type: Observational

The study intends to measure fibrinogen plasma levels during the first 24 hrs in cardiac and thoracic surgical patients who undergo surgical procedures using extracorporeal circulation.

NCT ID: NCT02604875 Completed - Circadian Rhythm Clinical Trials

The Circadian Rhythm of Copeptin

Co-Rhythm
Start date: November 2015
Phase: N/A
Study type: Observational

The circadian rhythm of copeptin will be examined in healthy subjects.

NCT ID: NCT02604602 Completed - Clinical trials for Postpartum Hemorrhage

Coagulation Factors and Postpartum Hemorrhage

Start date: October 2015
Phase:
Study type: Observational [Patient Registry]

Objective is to analyze a possible association of coagulation factors peripartal with the occurrence of postpartum hemorrhage.

NCT ID: NCT02603094 Completed - Clinical trials for Preoperative Fasting

Gastric pH in Intubated Children - Part Two

Start date: December 2015
Phase: N/A
Study type: Interventional

Fasting (according to ASA, ESA or institutional guidelines) is an important strategy to minimize the risk of regurgitation, vomiting and pulmonary aspiration during general anaesthesia; the effect of fasting time for clear fluid on gastric pH in children is goal of this study and can be investigated in children undergoing elective procedures in general anaesthesia and intubation without inconvenience or additional invasive procedure and hence without additional risk Hypotheses: Gastric pH is higher in children that drink clear fluids until premedication before anaesthesia induction than in those that drink until 2 hours before anaesthesia induction

NCT ID: NCT02602158 Completed - Healthy Clinical Trials

13C Trioctanoate Breath Test as a Measurement of Gastric Fat Volume Emptying

13CTriOBT
Start date: October 2015
Phase: Phase 0
Study type: Interventional

13C breath tests represent an attractive alternative in the measurement of gastric emptying (GE). Therefore these tests have been used in a variety of clinical settings such as in the assessment of gastroparesis, delayed GE in diabetic patients or in the assessment of GE with fat containing enteral formulas in critically ill patients. The investigators have previously demonstrated that the 13C sodium octanoate breath test (OBT) is an inappropriate measurement method for the GE of fat. The OBT appears to be affected by 1) post gastric processing of the OCC marker and 2) its interaction with the physical form and concentration of the fat present in the stomach and duodenum. The13C trioctanoate breath test (TriOBT) represents an attractive alternative to the OBT. Compared to OCC which is a medium chain fatty acid the 13C trioctanoate (TriOCC) is a triglyceride. TriOCC has similar physio chemical properties as the nutritional lipid e.g. rapeseed oil. This study aims to assess the efficacy of the TriOBT as a GE measurement method of fat in an acid stable lipid emulsion (LE1). The breath test results from the TriOBT will be compared with the OBT and further validated against gastric fat volume emptying data observed from MRI. The interim analysis will determine whether the study will proceed to stage 2 which will assess the efficacy of the TriOBT in an acid unstable lipid emulsion (LE4).

NCT ID: NCT02601846 Completed - Pulmonary Embolism Clinical Trials

Age-adjusted D-dimer Cut-off to Rule Out Pulmonary Embolism in the Emergency Department : A Real Life Impact Study

RELAX-PE
Start date: November 2015
Phase:
Study type: Observational

A multicentre multinational prospective management outcome study has recently proven the safety of a diagnostic strategy combining clinical probability assessment with an age-adjusted D-dimer cut-off, defined as a value of (age x 10) in patients > 50 years, for ruling out PE in outpatients, with a very low likelihood of subsequent symptomatic VTE. Moreover, this study showed that such a strategy increased the diagnostic yield of D-dimers, as it allowed ruling out PE without further investigation in a significantly higher proportion of patients than when using standard cut-off, particularly so in patients 75 years or older. The objective of the present study is to confirm in a prospective cohort of "real life" patients the usefulness of the age-adjusted D-dimer cut-off to rule out PE in patients presenting to the emergency department with suspected PE.

NCT ID: NCT02601092 Recruiting - Obesity Clinical Trials

Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Mini Gastric Bypass

MGB
Start date: October 2016
Phase: N/A
Study type: Interventional

Several retrospective studies have shown same efficiency in regard to weight loss, with a lower rate of complications for the laparoscopic mini gastric bypass (LMGB) compared to Roux-en-Y gastric bypass (LRYGB). The aim of this double-blinded randomized controlled trial is to compare the two procedures in respect of excess weight loss, complications, operation time, length of stay and the metabolic impact on the hormonal brain-gut-axis.

NCT ID: NCT02600663 Terminated - Back Pain Clinical Trials

Identification of Patients at Risk of Chronic Back Pain Using Questionnaires

chron_pain
Start date: April 1, 2016
Phase:
Study type: Observational

Patients with acute back pain (<6 weeks) presenting at their general practitioner will be enrolled. Patients fulfilling all inclusion criteria and showing no exclusion criteria will fill out the Heidelberg short questionnaire (HKF-R10) and the Keele STarT Back Screening Tool. These two questionnaires categorize back pain patients into individuals at risk of chronic back pain and those not at risk. Furthermore, data concerning pain location, severity, duration and impairment will be collected. Study participants will receive standard care treatment prescribed by their general practitioner. Six months later, study participants will receive a questionnaire in order to collect data concerning their present pain situation. Patients with relevant impairment in their activities of daily living as a result of back pain will be categorized as individuals with chronic back pain. Categorization at six months will be compared with the categorization at presentation.